Interstitial pneumonitis induced by bicalutamide and leuprorelin acetate for prostate cancer

Int J Urol. 2003 Nov;10(11):625-6. doi: 10.1046/j.1442-2042.2003.00705.x.

Abstract

Maximal androgen blockade therapy is the standard endocrine treatment for advanced prostate cancer. We report here an unusual case of interstitial pneumonitis induced by bicalutamide and/or leuprorelin acetate treatment for metastatic prostate cancer.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Anilides / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Follow-Up Studies
  • Glucocorticoids / administration & dosage
  • Humans
  • Leuprolide / administration & dosage
  • Lung Diseases, Interstitial / chemically induced*
  • Lung Diseases, Interstitial / diagnosis
  • Lung Diseases, Interstitial / drug therapy
  • Male
  • Methylprednisolone Hemisuccinate / administration & dosage
  • Nitriles
  • Prostatic Neoplasms / drug therapy*
  • Tosyl Compounds
  • Treatment Outcome

Substances

  • Anilides
  • Glucocorticoids
  • Nitriles
  • Tosyl Compounds
  • Methylprednisolone Hemisuccinate
  • bicalutamide
  • Leuprolide